TP53 mutations were the most common mutations identified and were present in 10 out of 13 tumors (77%), which is comparable to prior studies showing frequent TP53 mutations in BRCA mutant breast cancers (Fig. 1a)39. Here, TP53 is linked to breast carcinoma.